Scholarlink

Background and Aims <p>Bilateral intraductal plastic stent (IS) placement is preferred for unresectable malignant hilar biliary obstruction (MHBO) owing to its stent patency and removability. However, certain clinical and technical conditions permit only unilateral drainage even for unresectable MHBO. A useful stent selection in such cases remains unclear.</p> Methods <p>Among 360 retrospective patients with MHBO, 118 underwent unilateral drainage with an across-papillary plastic stent (PS), IS, or a self-expandable metallic stent (SEMS). Outcomes were compared based on clinical success, adverse events (AEs), recurrent biliary obstruction (RBO), time to RBO (TRBO), and reintervention, using propensity score matching (PSM) analysis.</p> Results <p>PSM identified 23 patients in each group for comparison. The RBO occurrence rates and median TRBO were 83%, 65%, and 48% (<i>P</i> = 0.054), and 44-days, 130-days, and 231-days in the PS, IS, and SEMS groups (<i>P</i> &lt; 0.01), respectively. Post hoc tests showed that TRBO was significantly shorter in the PS group than in the IS (<i>P</i> = 0.04) and SEMS (<i>P</i> &lt; 0.01) groups. In multivariate analysis, PS was a significant TRBO-related factor (hazard ratio 2.56, <i>P</i> &lt; 0.01). There were no significant differences in the technical success rates, clinical success rates, procedure times, AEs, or TRBO after reintervention in the PS, IS, and SEMS groups.</p> Conclusions <p>Unilateral IS has longer stent patency than PS, better removability, and a higher technical success rate of reintervention than SEMS. IS may be a good option when only a unilateral drainage approach is available in patients with unresectable MHBO.</p> Clinical Trial Registry Number <p>UMIN000057659</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Evaluation of Useful Stent Selection in Unresectable Malignant Hilar Biliary Obstruction with a Unilateral Drainage Route: Propensity Score Matching Analysis

  • 期刊论文

  • 发表日期：

    2026年4月1日

查看全文
  • Mitsuru Okuno,
  • Tsuyoshi Mukai,
  • Fumiya Kataoka,
  • Keisuke Iwata,
  • Ryuichi Tezuka,
  • Yuhei Iwasa,
  • Takuya Koizumi,
  • Kota Shimojo,
  • Yosuke Ohashi,
  • Shota Iwata,
  • Naoki Mita,
  • Akinori Maruta,
  • Shinya Uemura,
  • Hironao Ichikawa,
  • Kensaku Yoshida,
  • Takuji Iwashita,
  • Eiichi Tomita,
  • Ichiro Yasuda,
  • Hisataka Moriwaki,
  • Masahito Shimizu

摘要

Background and Aims

Bilateral intraductal plastic stent (IS) placement is preferred for unresectable malignant hilar biliary obstruction (MHBO) owing to its stent patency and removability. However, certain clinical and technical conditions permit only unilateral drainage even for unresectable MHBO. A useful stent selection in such cases remains unclear.

Methods

Among 360 retrospective patients with MHBO, 118 underwent unilateral drainage with an across-papillary plastic stent (PS), IS, or a self-expandable metallic stent (SEMS). Outcomes were compared based on clinical success, adverse events (AEs), recurrent biliary obstruction (RBO), time to RBO (TRBO), and reintervention, using propensity score matching (PSM) analysis.

Results

PSM identified 23 patients in each group for comparison. The RBO occurrence rates and median TRBO were 83%, 65%, and 48% (P = 0.054), and 44-days, 130-days, and 231-days in the PS, IS, and SEMS groups (P < 0.01), respectively. Post hoc tests showed that TRBO was significantly shorter in the PS group than in the IS (P = 0.04) and SEMS (P < 0.01) groups. In multivariate analysis, PS was a significant TRBO-related factor (hazard ratio 2.56, P < 0.01). There were no significant differences in the technical success rates, clinical success rates, procedure times, AEs, or TRBO after reintervention in the PS, IS, and SEMS groups.

Conclusions

Unilateral IS has longer stent patency than PS, better removability, and a higher technical success rate of reintervention than SEMS. IS may be a good option when only a unilateral drainage approach is available in patients with unresectable MHBO.

Clinical Trial Registry Number

UMIN000057659